Stay updated on Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial
Sign up to get notified when there's something new on the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page.

Latest updates to the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study page now shows Revision: v3.6.3, replacing the previous v3.6.0. This indicates a minor page update to the study record without changing core content such as eligibility criteria or outcomes.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedA new revision tag v3.5.5 was added and the previous v3.5.4 tag removed, indicating a minor update to the page's revision history.SummaryDifference0.1%

- Check56 days agoChange DetectedThe study record now shows revision v3.5.4, replacing v3.5.3. This indicates a new release of the page, typically reflecting minor edits to metadata or presentation rather than changes to the study data.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision: v3.5.3 is now shown on the study page, indicating a newer version of the page content. This appears to be an administrative update rather than a substantive change to the study information.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check114 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page.